293 related articles for article (PubMed ID: 35830641)
1. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
Wu YW; Comstock BA; Gonzalez FF; Mayock DE; Goodman AM; Maitre NL; Chang T; Van Meurs KP; Lampland AL; Bendel-Stenzel E; Mathur AM; Wu TW; Riley D; Mietzsch U; Chalak L; Flibotte J; Weitkamp JH; Ahmad KA; Yanowitz TD; Baserga M; Poindexter BB; Rogers EE; Lowe JR; Kuban KCK; O'Shea TM; Wisnowski JL; McKinstry RC; Bluml S; Bonifacio S; Benninger KL; Rao R; Smyser CD; Sokol GM; Merhar S; Schreiber MD; Glass HC; Heagerty PJ; Juul SE;
N Engl J Med; 2022 Jul; 387(2):148-159. PubMed ID: 35830641
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
Juul SE; Comstock BA; Wadhawan R; Mayock DE; Courtney SE; Robinson T; Ahmad KA; Bendel-Stenzel E; Baserga M; LaGamma EF; Downey LC; Rao R; Fahim N; Lampland A; Frantz ID; Khan JY; Weiss M; Gilmore MM; Ohls RK; Srinivasan N; Perez JE; McKay V; Vu PT; Lowe J; Kuban K; O'Shea TM; Hartman AL; Heagerty PJ;
N Engl J Med; 2020 Jan; 382(3):233-243. PubMed ID: 31940698
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.
Rogers EE; Bonifacio SL; Glass HC; Juul SE; Chang T; Mayock DE; Durand DJ; Song D; Barkovich AJ; Ballard RA; Wu YW
Pediatr Neurol; 2014 Nov; 51(5):657-62. PubMed ID: 25439577
[TBL] [Abstract][Full Text] [Related]
4. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
[TBL] [Abstract][Full Text] [Related]
5. Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
Maiwald CA; Annink KV; Rüdiger M; Benders MJNL; van Bel F; Allegaert K; Naulaers G; Bassler D; Klebermaß-Schrehof K; Vento M; Guimarães H; Stiris T; Cattarossi L; Metsäranta M; Vanhatalo S; Mazela J; Metsvaht T; Jacobs Y; Franz AR;
BMC Pediatr; 2019 Jun; 19(1):210. PubMed ID: 31248390
[TBL] [Abstract][Full Text] [Related]
6. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
[TBL] [Abstract][Full Text] [Related]
7. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial.
Malla RR; Asimi R; Teli MA; Shaheen F; Bhat MA
J Perinatol; 2017 May; 37(5):596-601. PubMed ID: 28277490
[TBL] [Abstract][Full Text] [Related]
9. Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.
Shankaran S; Laptook AR; Pappas A; McDonald SA; Das A; Tyson JE; Poindexter BB; Schibler K; Bell EF; Heyne RJ; Pedroza C; Bara R; Van Meurs KP; Huitema CMP; Grisby C; Devaskar U; Ehrenkranz RA; Harmon HM; Chalak LF; DeMauro SB; Garg M; Hartley-McAndrew ME; Khan AM; Walsh MC; Ambalavanan N; Brumbaugh JE; Watterberg KL; Shepherd EG; Hamrick SEG; Barks J; Cotten CM; Kilbride HW; Higgins RD;
JAMA; 2017 Jul; 318(1):57-67. PubMed ID: 28672318
[TBL] [Abstract][Full Text] [Related]
10. Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial.
Juul SE; Voldal E; Comstock BA; Massaro AN; Bammler TK; Mayock DE; Heagerty PJ; Wu YW; Numis AL;
JAMA Netw Open; 2023 Jul; 6(7):e2322131. PubMed ID: 37418263
[TBL] [Abstract][Full Text] [Related]
11. Association of EEG Background and Neurodevelopmental Outcome in Neonates With Hypoxic-Ischemic Encephalopathy Receiving Hypothermia.
Glass HC; Numis AL; Comstock BA; Gonzalez FF; Mietzsch U; Bonifacio SL; Massey S; Thomas C; Natarajan N; Mayock DE; Sokol GM; Van Meurs KP; Ahmad KA; Maitre N; Heagerty PJ; Juul SE; Wu YW; Wusthoff CJ
Neurology; 2023 Nov; 101(22):e2223-e2233. PubMed ID: 37816642
[TBL] [Abstract][Full Text] [Related]
12. Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.
Laptook AR; Shankaran S; Tyson JE; Munoz B; Bell EF; Goldberg RN; Parikh NA; Ambalavanan N; Pedroza C; Pappas A; Das A; Chaudhary AS; Ehrenkranz RA; Hensman AM; Van Meurs KP; Chalak LF; Khan AM; Hamrick SEG; Sokol GM; Walsh MC; Poindexter BB; Faix RG; Watterberg KL; Frantz ID; Guillet R; Devaskar U; Truog WE; Chock VY; Wyckoff MH; McGowan EC; Carlton DP; Harmon HM; Brumbaugh JE; Cotten CM; Sánchez PJ; Hibbs AM; Higgins RD;
JAMA; 2017 Oct; 318(16):1550-1560. PubMed ID: 29067428
[TBL] [Abstract][Full Text] [Related]
13. Time to Reaching Target Cooling Temperature and 2-year Outcomes in Infants with Hypoxic-Ischemic Encephalopathy.
Rao R; Comstock BA; Wu TW; Mietzsch U; Mayock DE; Gonzalez FF; Wood TR; Heagerty PJ; Juul SE; Wu YW
J Pediatr; 2024 Mar; 266():113853. PubMed ID: 38006967
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
[TBL] [Abstract][Full Text] [Related]
15. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial.
Jacobs SE; Morley CJ; Inder TE; Stewart MJ; Smith KR; McNamara PJ; Wright IM; Kirpalani HM; Darlow BA; Doyle LW;
Arch Pediatr Adolesc Med; 2011 Aug; 165(8):692-700. PubMed ID: 21464374
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic-Ischemic Encephalopathy: Volume of Acute Brain Injury and 1-Year Neurodevelopmental Outcome.
Mulkey SB; Ramakrishnaiah RH; McKinstry RC; Chang T; Mathur AM; Mayock DE; Van Meurs KP; Schaefer GB; Luo C; Bai S; Juul SE; Wu YW
J Pediatr; 2017 Jul; 186():196-199. PubMed ID: 28456387
[TBL] [Abstract][Full Text] [Related]
17. Cooling for newborns with hypoxic ischaemic encephalopathy.
Jacobs SE; Berg M; Hunt R; Tarnow-Mordi WO; Inder TE; Davis PG
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003311. PubMed ID: 23440789
[TBL] [Abstract][Full Text] [Related]
18. Association of cerebral metabolic rate following therapeutic hypothermia with 18-month neurodevelopmental outcomes after neonatal hypoxic ischemic encephalopathy.
Sutin J; Vyas R; Feldman HA; Ferradal S; Hsiao CH; Zampolli L; Pierce LJ; Nelson CA; Morton SU; Hay S; El-Dib M; Soul JS; Lin PY; Grant PE
EBioMedicine; 2023 Aug; 94():104673. PubMed ID: 37392599
[TBL] [Abstract][Full Text] [Related]
19. Temporal evolution of electrographic seizures in newborn infants with hypoxic-ischaemic encephalopathy requiring therapeutic hypothermia: a secondary analysis of the ANSeR studies.
Pavel AM; Rennie JM; de Vries LS; Mathieson SR; Livingstone V; Finder M; Foran A; Shah DK; Pressler RM; Weeke LC; Dempsey EM; Murray DM; Boylan GB;
Lancet Child Adolesc Health; 2024 Mar; 8(3):214-224. PubMed ID: 38246187
[TBL] [Abstract][Full Text] [Related]
20. The effects of monotherapy with erythropoietin in neonatal hypoxic-ischemic encephalopathy on neurobehavioral development: a systematic review and meta-analysis.
Liu TS; Yin ZH; Yang ZH; Wan LN
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2318-2326. PubMed ID: 33755969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
